Caprelsa (Vandetanib) belongs to a class of Tyrosine Kinase inhibitors (TKI), commonly used to treat thyroid cancer with drugs (medullary form). To ensure the best effect of the drug, the patient needs to follow the instructions of the doctor or pharmacist.